Wang Zhiheng

Deputy Chief Physician

He is skilled in vascular interventional therapy, ablation, and targeted therapy for various malignant solid tumors, and possesses extensive clinical experience in the standardized treatment of advanced malignant tumors.

Introduction of the expert

Wang Zhiheng, an associate chief physician and medical master, is a high-level talent (Category E) in other fields in Hainan Province and an evaluation expert of the Science and Technology Department of Hainan Province. He graduated from Harbin Medical University with a bachelors degree and from Fujian Medical University with a masters degree. With years of experience in interventional medicine, he possesses extensive clinical expertise in the interventional treatment of various diseases, specializing in yttrium 90 therapy for liver cancer, vascular intervention, tumor ablation, and radioactive particle implantation techniques. He has extensive clinical experience in the interventional treatment of solid tumors such as liver cancer, gastric cancer, lung cancer, and kidney cancer. He has published over 10 medical papers in core journals, with 3 papers indexed by SCI.

Medical specialty

Proficient in yttrium 90 therapy for liver cancer, vascular intervention, tumor ablation, and radioactive particle implantation techniques; possesses extensive clinical experience in the interventional treatment of solid tumors such as liver cancer, gastric cancer, lung cancer, and kidney cancer.

Direction of scientific research

Clinical research on the treatment of advanced breast cancer with drug-loaded microspheres and the treatment of liver malignancies with yttrium 90.

Academic association appointment

I. Secretary-General of the Tumor Internal Radiation Medicine Professional Committee of the China Medical Education Association

II. Director of the Interventional Medicine Innovation Alliance (IMIA) - Hainan Innovation Alliance, National Research Center for Radiation and Therapy Clinical Medicine

III. Member of the Second Hematology Professional Committee of the Chinese Research Hospital Association

IV. Vice Chairman of the Second Tumor Intervention Special Committee of the Hainan Provincial Anti-Cancer Association

V. Standing Committee Member of the First Committee of the Multidisciplinary Treatment (MDT) Specialty Committee of the Hainan Provincial Cancer Prevention and Treatment Association

VI. Standing Committee Member of the Second Committee of the Clinical Interventional Medicine Branch of the Hainan Provincial Medical Association

VII. Executive member of the Tumor Ablation Professional Committee of the Hainan Provincial Anti-Cancer Association

VIII. Executive Committee Member of the Second Committee of the Interventional Physicians Branch of the Hainan Provincial Medical Doctor Association

IX. Executive Committee Member of the First Committee of the Interventional Specialty Committee of the Hainan Provincial Non-Public Medical Institution Association

X. Secretary of the Standing Committee of the First Committee of the Tumor Intervention Specialty Committee of the Hainan Provincial Tumor Prevention and Treatment Association, and member of the First Committee of the Thyroid Tumor Specialty Committee

XI. member of the first committee of the Tumor Rehabilitation Professional Committee of the Hainan Provincial Anti-Cancer Association

XII. Member of the Expert Committee of the Medical Quality Control Center for Comprehensive Interventional Technology in Hainan Province (June 2023 - December 2024)

Papers and works

I. Xiaobin Feng, Lin Zhang, Huimin Niu, et al. Selective internal radiation therapy with yttrium-90 resin microspheres followed by anatomical hepatectomy: A potential curative strategy in advanced hepatocellular carcinoma. Asia-Pac J Clin Oncol. 2023:1–4.

II. Zhiheng Wang, Huimin Niu, Zhiyong Li, et al. Superselective arterial embolization with drug-loaded microspheres for the treatment of unresectable breast cancer. Gland Surg 2019; 8 (6): 740-747.

III. Wang Z, Qi W, Hu Y, et al. Mixed-Type Total Anomalous Pulmonary Venous Connection in an Adult[J]. Annals of Thoracic Surgery, 2011, 91(2):610.

IV. Shutang B, Zhiheng W, Liang Z, et al. Successful surgical treatment of descending aorta interruption in a 29-year-old woman with acute paraplegia and subarachnoid hemorrhage: a case report. Journal of Cardiothoracic Surgery, 2015, 10:80.

V. Niu Huimin, Wang Zhiheng, Gao Shixin, Zeng Qian, Li Yinghui, Han Yue, Application and Progress of Yttrium-90 Microspheres in Liver Malignant Tumors, Electronic Journal of Liver Cancer, 2021, 8(4): 36-40.

VI. Wang Zhiheng, Qi Weibo, Kang Mingqiang, Chen Chun, Zhu Yong, Lin Ruobai, Clinical Application of Video Mediastinoscopy and CT in the Diagnosis of Thoracic Diseases, Chinese Journal of Endoscopy, 2010, 6: 584-587.

VII. Wang Zhiheng, Qi Weibo, Zhu Yong, Lin Ruobai, Application of Video Mediastinoscopy and CT in Preoperative Lung Cancer N-Staging, Chinese Journal of Lung Cancer, 2009, 10:1085-1088.

VII. Wang Zhiheng, Lin Ruobai, Clinical application of video mediastinoscopy, International Journal of Surgery, 2008, 3:189-191.

XI. Wang Zhiheng, Lin Ruobai, Advances in the treatment of ischemia-reperfusion injury in lung transplantation, International Journal of Transplantation and Blood Purification, 2008, 1:22-24.